Gene predicts how fast Alzheimer's progress
(could help people with learning problems)
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
People with a specific genetic variation develop Alzheimer's disease at a faster rate than others, U.S. researchers said on Thursday in a finding that may help in the search for drugs to keep the disease at bay. They said a mutation of a gene that regulates tau -- a protein linked with Alzheimer's -- had a strong impact on the rate at which the disease progresses. Drugs that interfere with this form of tau may offer a new way to keep the disease from advancing, a team from Washington University in St. Louis reported in the journal PLoS Genetics.
The team has filed for a patent, and it said the Anglo-Swedish drug company AstraZeneca had an option to license it. "People who carry this genetic marker tend to have higher tau levels at any given stage of the disease than individuals without it," Alison Goate, who worked on the study, said in a statement.
Alzheimer's, the most common form of dementia, is a fatal brain disease in which people gradually lose their memory and their ability to reason and care for themselves. Goate's team looked at a form of the protein tau that accumulates in the brains of people with Alzheimer's disease and that can also be found in spinal fluid. Her team looked for single letter changes in the DNA code of genes that affect tau metabolism. They studied more than 800 people and found one version of the gene that regulates tau is linked with more aggressive Alzheimer's disease.
The findings suggest that drugs that interfere with this gene variant might be able to delay the rapid progression of the disease. Read more: reuters.co
Yeast as save source for use in dietary supplement
The safety of an EPA-rich oil from genetically modified yeast is “comparable to that of GRAS fish oil”, says a new study from DuPont. Read more: nutraingredients.com
No comments:
Post a Comment